Ying Tian
Verified
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Ying
Contact Ying, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck RackActions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Articles
TCR-JANUS engager proteins enable bispecific targeting to overcome tumor heterogeneity in TCR-T cell therapy
Abstract INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS Acknowledgments Supplementary Materials REFERENCES Information & Authors Metrics & Citations View Options References Figures Tables Media Share This article has 0 eLetter . Abstract T cell receptor (TCR)–based immunotherapy is limited by tumor antigen heterogeneity, which frequently leads to relapse. We developed a bispecific TCR-JANUS engager that functions synergistically with TCR engineered T cells (TCR-T).
Electrogram-Guided Driver Ablation Versus Posterior Wall Isolation in Persistent AF: A Propensity-Matched Study
Conflicts of Interest The authors declare no conflicts of interest. Data Availability Statement The data that support the findings of this study are available from the corresponding author upon reasonable request.
Adverse outcomes of sarcopenic obesity in older adults: a scoping review
Abstract Introduction: Sarcopenic obesity (SO) has been shown to have a substantial impact on health. However, the current understanding of adverse outcomes associated with SO is incomplete.
Actions
Get in touch with Ying
Contact Ying, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack